300750 Contemporary Amperex Technology (A)

NEX EXCHANGE: APPLICATION FOR ADMISSION - WORLD HIGH LIFE PLC

NEX Exchange (NEXX)
NEX EXCHANGE: APPLICATION FOR ADMISSION - WORLD HIGH LIFE PLC

03-Sep-2019 / 16:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


RULE 23 - PROFORMA PRE-ADMISSION ANNOUNCEMENT
 
ANNOUNCEMENT OF APPLICATION FOR ADMISSION TO THE NEX EXCHANGE GROWTH MARKET
 
APPLICANT NAME:

WORLD HIGH LIFE PLC
 
APPLICANT REGISTERED OFFICE, PRINCIPLE PLACE OF BUSINESS (IF DIFFERENT) AND TELEPHONE NUMBER:

Registered Office and principle place of business:
The Broadgate Tower, 20 Primrose Street, London EC2A 2EW

Telephone number:
+44 (0) 20 3983 3098
 
DIRECTORS AND PROPOSED DIRECTORS (IF APPLICABLE):

David Stadnyk (Chairman and Chief Executive Officer)
Robert Payment (Executive Director and Chief Financial Officer)            
Kevin Ernst (Non-Executive Director)
Charles ("Charlie") Lamb (Independent Non-Executive Director)
 
APPLICANT SECTOR:

Financial Services
 
DESCRIPTION OF THE APPLICANT AND ITS ACTIVITIES:

The Company was incorporated on 30 January 2019 as an Investment Vehicle to identify investment opportunities and acquisitions in companies to specifically take advantage of the rapidly changing regulatory environment surrounding legal Medicinal Cannabis as well as investment opportunities within the Hemp and CBD wellness sectors.

The investment strategy of the Company is to focus on making investments and/or to acquire companies operating within the burgeoning legal Medicinal Cannabis, Hemp and CBD industries to achieve an attractive total return primarily through capital appreciation.

The Company has raised £2,398,309 through three issues of Ordinary Shares to private subscribers between 26 June 2019 and 27 August 2019.
 
NAME OF NEX EXCHANGE CORPORATE ADVISER:

Peterhouse Capital Limited
80 Cheapside
London
EC2V 6EE
 
NUMBER, CLASS AND PAR VALUE OF SECURITIES TO BE ADMITTED:

110,398,091 ordinary shares of 1p each
 
SECURITIES IN PUBLIC HANDS AS A PERCENTAGE OF THE TOTAL NUMBER OF SECURITIES IN ISSUE (excluding securities held in treasury):

11.28 per cent.
 
SHAREHOLDERS HOLDING MORE THAN FIVE PER CENT OF THE APPLICANT'S SHARE CAPITAL OR VOTING RIGHTS PRE- AND POST-ADMISSION:
 
Shareholder Shareholding % of Share Capital
Christine McIntosh 19,333,333 17.51%
David Stadnyk 13,501,000 12.23%
Paul Saunders 10,666,667 9.66%
Andrew MacDonald 9,180,000 8.32%
Fortius Research & Trading Corp 5,700,000 5.16%
Fab Carella 5,670,000 5.14%
Litsa Perperidis 5,666,667 5.13%
TY & Sons Investments Inc 5,666,667 5.13%
 
TIMETABLE FOR ANY OFFER OF TRANSFERRABLE SECURITIES TO THE PUBLIC:

N/A
 
THE EXPECTED ADMISSION DATE:

12 September 2019
 
WEBSITE ADDRESS WHERE INVESTOR INFORMATION WILL BE AVAILABLE FOR INSPECTION:


 


Category Code: MSCL
TIDM: NEXX
LEI Code: 213800AMGNBSOCOSDN11
Sequence No.: 18843
EQS News ID: 867819

 
End of Announcement EQS News Service

fncls.ssp?fn=show_t_gif&application_id=867819&application_name=news&site_id=research_pool
EN
03/09/2019

Underlying

300750Contemporary Amperex Technology (A)

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Contemporary Amperex Technology (A)

 PRESS RELEASE

DGAP-News: ADL Bionatur Solutions Wins New Fermentation Client With Co...

DGAP-News: ADL Bionatur Solutions / Key word(s): Agreement ADL Bionatur Solutions Wins New Fermentation Client With Contract Revenues of EUR 20 Million 02.12.2019 / 09:06 The issuer is solely responsible for the content of this announcement. ADL BIONATUR SOLUTIONS WINS NEW FERMENTATION CLIENT WITH CONTRACT REVENUES OF EUR 20 MILLION The agreement with a leading Swiss biotech company includes technology transfer, upscaling and industrial-scale production of high value-added innovative ingredients for the cosmetics and nutrition industry ADL to apply its expertise in a...

 PRESS RELEASE

Admission of Security to Trading

NEX Exchange (NEXX) Admission of Security to Trading 02-Dec-2019 / 07:30 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. The following security will be admitted to trading on the NEX Exchange Growth Market with effect from 08:00, 02/12/2019. Name of Issuer: Dozens Savings Plc 5.00% Secured Bonds due 2 December 2020 ISIN: GB00BL1GTZ11  Symbol: DS04 EMS: 1 The Regulation Department NEX Exchange London Fruit & Wool Exchange 1 Duval Square London E1 6PW Tel: 020 7858 1655 Email:   W...

 PRESS RELEASE

Admission of Security to Trading

NEX Exchange (NEXX) Admission of Security to Trading 02-Dec-2019 / 07:30 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. The following security will be admitted to trading on the NEX Exchange Growth Market with effect from 08:00, 02/12/2019. Name of Issuer: SAPO PLC Ordinary Shares of GBP 0.01 ISIN: GB00B16GQJ90 Symbol: SAPO EMS: 5000 The Regulation Department NEX Exchange London Fruit & Wool Exchange 1 Duval Square London E1 6PW Tel: 020 7858 1655 Email:   Website: ...

 PRESS RELEASE

EQS-News: LIWET HOLDING AG publishes open letter to Dr. Martin Haefner...

EQS Group-News: Dynamics Group AG / Key word(s): Statement/Corporate Action LIWET HOLDING AG publishes open letter to Dr. Martin Haefner in various Swiss Sunday newspapers 01.12.2019 / 05:59 Open letter to Dr. Martin Haefner Dear Mr Haefner We share your concern about the future of Schmolz+Bickenbach (S+B). The company urgently needs money, everyone - including Liwet - agrees. However, there is still time to find a constructive solution for S+B that is in the interest of all, not only one particular shareholder. Liwet is ready to rescue the company and the 10,000 jobs. Liw...

 PRESS RELEASE

EQS-News: LIWET HOLDING AG publiziert offenen Brief an Dr. Martin Haef...

EQS Group-News: Dynamics Group AG / Schlagwort(e): Stellungnahme/Kapitalmaßnahme LIWET HOLDING AG publiziert offenen Brief an Dr. Martin Haefner in verschiedenen Schweizer Sonntagszeitungen 01.12.2019 / 05:59 Offener Brief an Dr. Martin Haefner Sehr geehrter Herr Haefner Wir teilen Ihre Sorge um die Zukunft von Schmolz+Bickenbach (S+B). Die Firma braucht dringend Geld; damit sind alle - auch Liwet - einverstanden. Noch bleibt Zeit, um eine konstruktive Lösung für S+B zu finden, die im Interesse aller Aktionäre ist, nicht nur eines einzigen. Liwet steht bereit, die Fir...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch